Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FR8FN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,785.80 by the Defense Logistics Agency on September 4, 2025, for Nucala 100 mg/mL auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of September 5, 2025, carries no set-aside designation, allowing the vendor to compete on an open basis. The contract represents a specific pharmaceutical product delivery under DMS Pharmaceutical Group's existing relationship with DLA for medical supply distribution.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The SPE2DB program IDC enables DLA to procure a comprehensive range of pharmaceutical products—including branded and generic prescription drugs, over-the-counter medications, biologics, and specialized medical consumables—to support the medical supply needs of Department of Defense healthcare facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription medications and pharmacy services to military health facilities across the globe.
Quick answers
Who was awarded contract SPE2DB25FR8FN?
SPE2DB25FR8FN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FR8FN worth?
The government has obligated $3,786 on SPE2DB25FR8FN.
Is contract SPE2DB25FR8FN an order under another contract?
Yes. SPE2DB25FR8FN is a delivery order under SPE2DB22D9225, an indefinite delivery contract.
Was contract SPE2DB25FR8FN competed?
The extent of competition for SPE2DB25FR8FN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award